http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003040467-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2264 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5759 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
| filingDate | 1998-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef990c768db5261accb5c55b2c2f4011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a629393d4c933a4140d9a09c2c0aed6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7895843c1ef6a448ea838e1caae458f |
| publicationDate | 2003-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2003040467-A1 |
| titleOfInvention | Ig/ob fusions and uses thereof. |
| abstract | The present invention stems from the observation that administration of OB protein to non-obese as well as obese animals results in an increase of lean tissue mass. Thus, OB protein has the capacity to act, in addition to acting as a weight reducing agent, as an agent affecting lean tissue mass. As such, numerous lean tissue-mass increasing therapies are contemplated, even for patients who would not necessarily benefit from weight reduction. Thus, one aspect of the present invention is the use of OB protein (or analogs or derivatives thereof) for increasing lean tissue mass. |
| priorityDate | 1998-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 398.